On the public citation graph

Elaborate Ligand-Based Modeling Reveals New Nanomolar Heat Shock Protein 90α Inhibitors

0 signed · 106 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1439-7633(20020301)3:2/3<246::aid-cbic246>3.0.co;2-#openalex-snapshot

pH‐Dependent Binding Modes Observed in Trypsin Crystals: Lessons for Structure‐Based Drug Design

inferredcites →https://doi.org/10.1002/cmdc.200800213openalex-snapshot

Discovery of DPP IV Inhibitors by Pharmacophore Modeling and QSAR Analysis followed by in silico Screening

inferredcites →https://doi.org/10.1002/series6138openalex-snapshot

Methods and Principles in Medicinal Chemistry

inferredcites →https://doi.org/10.1007/s10822-007-9163-6openalex-snapshot

Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection—What can we learn from earlier mistakes?

inferredcites →https://doi.org/10.1016/0003-2697(79)90115-5openalex-snapshot

An improved assay for nanomole amounts of inorganic phosphate

inferredcites →https://doi.org/10.1016/j.ab.2003.10.038openalex-snapshot

High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity

inferredcites →https://doi.org/10.1016/j.ab.2005.12.023openalex-snapshot

A fluorescence polarization assay for inhibitors of Hsp90

inferredcites →https://doi.org/10.1016/j.bmc.2005.09.027openalex-snapshot

Development and optimization of a useful assay for determining Hsp90’s inherent ATPase activity

inferredcites →https://doi.org/10.1016/j.bmc.2007.10.076openalex-snapshot

Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening

inferredcites →https://doi.org/10.1016/j.bmc.2008.05.047openalex-snapshot

Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling

inferredcites →https://doi.org/10.1016/j.bmc.2010.03.043openalex-snapshot

Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent β-secretase inhibitory leads

inferredcites →https://doi.org/10.1016/j.bmcl.2005.08.092openalex-snapshot

Structure-based discovery of a new class of Hsp90 inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2006.01.086openalex-snapshot

Radanamycin, a macrocyclic chimera of radicicol and geldanamycin

inferredcites →https://doi.org/10.1016/j.bmcl.2006.01.099openalex-snapshot

4-Amino derivatives of the Hsp90 inhibitor CCT018159

inferredcites →https://doi.org/10.1016/j.bmcl.2006.02.063openalex-snapshot

High-throughput screening for Hsp90 ATPase inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2007.08.069openalex-snapshot

A novel class of Hsp90 inhibitors isolated by structure-based virtual screening

inferredcites →https://doi.org/10.1016/j.bmcl.2008.01.075openalex-snapshot

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE): Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents

inferredcites →https://doi.org/10.1016/j.bmcl.2008.08.022openalex-snapshot

Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: Heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay

inferredcites →https://doi.org/10.1016/j.drudis.2006.05.012openalex-snapshot

Virtual ligand screening: strategies, perspectives and limitations

inferredcites →https://doi.org/10.1016/j.ejmech.2009.12.070openalex-snapshot

Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration

inferredcites →https://doi.org/10.1016/j.ejmech.2010.01.016openalex-snapshot

3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors

inferredcites →https://doi.org/10.1016/j.jmb.2006.08.011openalex-snapshot

Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-crystallisation Conditions

inferredcites →https://doi.org/10.1016/j.jmgm.2006.08.008openalex-snapshot

Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening

inferredcites →https://doi.org/10.1016/j.jtice.2009.08.007openalex-snapshot

Bioinformatics, chemoinformatics, and pharmainformatics analysis of HER2/HSP90 dual-targeted inhibitors

inferredcites →https://doi.org/10.1016/j.str.2004.02.031openalex-snapshot

Heterogeneity and Inaccuracy in Protein Structures Solved by X-Ray Crystallography

inferredcites →https://doi.org/10.1016/j.tibs.2009.01.006openalex-snapshot

The complex dance of the molecular chaperone Hsp90

inferredcites →https://doi.org/10.1016/s0169-409x(00)00129-0openalex-snapshot

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

inferredcites →https://doi.org/10.1016/s0968-0896(02)00253-5openalex-snapshot

Development of a Purine-Scaffold Novel Class of Hsp90 Binders that Inhibit the Proliferation of Cancer Cells and Induce the Degradation of Her2 Tyrosine Kinase

inferredcites →https://doi.org/10.1016/s1093-3263(02)00164-xopenalex-snapshot

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites

inferredcites →https://doi.org/10.1016/s1359-6446(02)02411-xopenalex-snapshot

Why do we need so many chemical similarity search methods?

inferredcites →https://doi.org/10.1016/s1477-3627(02)02283-3openalex-snapshot

GPCRs: an update on structural approaches to drug discovery

inferredcites →https://doi.org/10.1021/ci034289qopenalex-snapshot

Virtual Screening Using Protein−Ligand Docking: Avoiding Artificial Enrichment

inferredcites →https://doi.org/10.1021/ci049714+openalex-snapshot

ZINC − A Free Database of Commercially Available Compounds for Virtual Screening

inferredcites →https://doi.org/10.1021/ci8003682openalex-snapshot

Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis, and Shape-Complemented in Silico Screening Allow Access to Novel Influenza Neuraminidase Inhibitors

inferredcites →https://doi.org/10.1021/ci980140gopenalex-snapshot

Binary Quantitative Structure−Activity Relationship (QSAR) Analysis of Estrogen Receptor Ligands

inferredcites →https://doi.org/10.1021/jm020017nopenalex-snapshot

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

inferredcites →https://doi.org/10.1021/jm021032vopenalex-snapshot

Non-Peptide Angiotensin II Receptor Antagonists: Chemical Feature Based Pharmacophore Identification

inferredcites →https://doi.org/10.1021/jm030896topenalex-snapshot

Improving Structure-Based Virtual Screening by Multivariate Analysis of Scoring Data

inferredcites →https://doi.org/10.1021/jm049012bopenalex-snapshot

Evaluation of 8-Arylsulfanyl, 8-Arylsulfoxyl, and 8-Arylsulfonyl Adenine Derivatives as Inhibitors of the Heat Shock Protein 90

inferredcites →https://doi.org/10.1021/jm049092jopenalex-snapshot

Virtual Screening Workflow Development Guided by the “Receiver Operating Characteristic” Curve Approach. Application to High-Throughput Docking on Metabotropic Glutamate Receptor Subtype 4

inferredcites →https://doi.org/10.1021/jm050752+openalex-snapshot

Rationally Designed High-Affinity 2-Amino-6-halopurine Heat Shock Protein 90 Inhibitors That Exhibit Potent Antitumor Activity

inferredcites →https://doi.org/10.1021/jm7009765openalex-snapshot

Pharmacophore Modeling, Quantitative Structure–Activity Relationship Analysis, and in Silico Screening Reveal Potent Glycogen Synthase Kinase-3β Inhibitory Activities for Cimetidine, Hydroxychloroquine, and Gemifloxacin

inferredcites →https://doi.org/10.1021/jm701018hopenalex-snapshot

4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

inferredcites →https://doi.org/10.1021/jm701385copenalex-snapshot

Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Heat Shock Protein 90

inferredcites →https://doi.org/10.1021/jm800718kopenalex-snapshot

Combining Ligand-Based Pharmacophore Modeling, Quantitative Structure−Activity Relationship Analysis and in Silico Screening for the Discovery of New Potent Hormone Sensitive Lipase Inhibitors

inferredcites →https://doi.org/10.1021/jm9602928openalex-snapshot

The Properties of Known Drugs. 1. Molecular Frameworks

inferredcites →https://doi.org/10.1046/j.1365-2141.2003.04746.xopenalex-snapshot

Long‐acting β2‐adrenergic formoterol and salmeterol induce the apoptosis of B‐chronic lymphocytic Leukaemia cells

inferredcites →https://doi.org/10.1074/jbc.m510142200openalex-snapshot

Intrinsic Inhibition of the Hsp90 ATPase Activity

inferredcites →https://doi.org/10.1111/j.1747-0285.2007.00535.xopenalex-snapshot

Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment‐based Design Strategies

inferredcites →https://doi.org/10.1136/pgmj.68.797.232openalex-snapshot

Davidson's Principles and Practice of Medicine

inferredcites →https://doi.org/10.2174/0929867013372481openalex-snapshot

Pharmacophore Modeling and Three-dimensional Database Searching for Drug Design Using Catalyst

inferredcites →https://doi.org/10.2174/1381612033454568openalex-snapshot

Pharmacophore Discovery - Lessons Learned

inferredcites →https://doi.org/10.2174/138955706778560166openalex-snapshot

Effectiveness of Hsp90 Inhibitors as Anti-Cancer Drugs

inferredcites →https://doi.org/10.2174/1568009033481877openalex-snapshot

Structure and Functional Relationships of Hsp90

inferredcites →https://doi.org/10.2174/156802606777811979openalex-snapshot

Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer

inferredcites →https://doi.org/10.2174/156802606777812068openalex-snapshot

Hsp90: A Novel Target for Cancer Therapy

inferredcites →https://doi.org/10.2174/156802606777812086openalex-snapshot

Discovery and Development of Pyrazole-Scaffold Hsp90 Inhibitors

inferredcites →https://doi.org/10.2174/187152006774755483openalex-snapshot

Emerging Hsp90 Inhibitors: From Discovery to Clinic

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/jmr.2604openalex-snapshot

Discovery of novel potent nuclear factor kappa‐B inhibitors (IKK‐β) via extensive ligand‐based modeling and virtual screening

inferred← citeshttps://doi.org/10.1002/minf.202400336openalex-snapshot

Discovery of New HER2 Inhibitors via Computational Docking, Pharmacophore Modeling, and Machine Learning

inferred← citeshttps://doi.org/10.1007/s00044-012-0204-xopenalex-snapshot

Ligand-based pharmacophore exploration and QSAR analysis of transition state analogues followed by in silico screening guide the discovery of new sub-micromolar β-secreatase inhibitors

inferred← citeshttps://doi.org/10.1007/s00044-014-0966-4openalex-snapshot

Elaborate ligand-based modeling reveals new human neutrophil elastase inhibitors

inferred← citeshttps://doi.org/10.1007/s00044-022-03001-xopenalex-snapshot

A Click Synthesis, Molecular Docking and Biological Evaluation of 1,2,3-triazoles-benzoxazepine hybrid as potential anticancer agents

inferred← citeshttps://doi.org/10.1007/s00044-023-03057-3openalex-snapshot

Development of phosphoinositide 3-kinase delta (PI3Kδ) inhibitors as potential anticancer agents through the generation of ligand-based pharmacophores and biological screening

inferred← citeshttps://doi.org/10.1007/s00044-025-03455-9openalex-snapshot

Identification and evaluation of potent AAK1 inhibitors through structure-based pharmacophores, virtual screening and bioassay screening

inferred← citeshttps://doi.org/10.1007/s00894-012-1479-zopenalex-snapshot

Application of docking-based comparative intermolecular contacts analysis to validate Hsp90α docking studies and subsequent in silico screening for inhibitors

inferred← citeshttps://doi.org/10.1007/s00894-014-2080-4openalex-snapshot

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

inferred← citeshttps://doi.org/10.1007/s10822-011-9509-yopenalex-snapshot

Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors

inferred← citeshttps://doi.org/10.1007/s10822-013-9637-7openalex-snapshot

QSAR model based on weighted MCS trees approach for the representation of molecule data sets

inferred← citeshttps://doi.org/10.1007/s10822-013-9699-6openalex-snapshot

Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors

inferred← citeshttps://doi.org/10.1007/s11030-022-10434-4openalex-snapshot

Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores

inferred← citeshttps://doi.org/10.1007/s11030-024-10814-yopenalex-snapshot

Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes

inferred← citeshttps://doi.org/10.1016/b978-0-12-814619-4.00020-3openalex-snapshot

High-Throughput Virtual Screening (HTVS) of Natural Compounds and Exploration of Their Biomolecular Mechanisms

inferred← citeshttps://doi.org/10.1016/b978-0-12-821748-1.00004-xopenalex-snapshot

Structure- and ligand-based drug design

inferred← citeshttps://doi.org/10.1016/j.bmc.2011.06.086openalex-snapshot

Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads

inferred← citeshttps://doi.org/10.1016/j.bmc.2011.10.071openalex-snapshot

Elaborate ligand-based modeling and subsequent synthetic exploration unveil new nanomolar Ca2+/calmodulin-dependent protein kinase II inhibitory leads

inferred← citeshttps://doi.org/10.1016/j.cbi.2016.03.006openalex-snapshot

Discovery of new selective cytotoxic agents against Bcl-2 expressing cancer cells using ligand-based modeling

inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2017.10.003openalex-snapshot

Ligand-based computational modelling of platelet-derived growth factor beta receptor leading to new angiogenesis inhibitory leads

inferred← citeshttps://doi.org/10.1016/j.ejmech.2011.03.040openalex-snapshot

Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling

inferred← citeshttps://doi.org/10.1016/j.ejmech.2014.07.056openalex-snapshot

Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis

inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.01.034openalex-snapshot

Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors

inferred← citeshttps://doi.org/10.1016/j.imu.2023.101332openalex-snapshot

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?

inferred← citeshttps://doi.org/10.1016/j.jmgm.2012.04.001openalex-snapshot

Extensive ligand-based modeling and in silico screening reveal nanomolar inducible nitric oxide synthase (iNOS) inhibitors

inferred← citeshttps://doi.org/10.1016/j.jmgm.2013.03.003openalex-snapshot

Elaborate ligand-based modeling reveal new migration inhibitory factor inhibitors

inferred← citeshttps://doi.org/10.1016/j.jmgm.2018.02.001openalex-snapshot

Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor

inferred← citeshttps://doi.org/10.1016/j.jmgm.2019.01.011openalex-snapshot

Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods

inferred← citeshttps://doi.org/10.1016/j.jmgm.2020.107615openalex-snapshot

Pharmacophore modeling of JAK1: A target infested with activity-cliffs

inferred← citeshttps://doi.org/10.1021/ci100368topenalex-snapshot

Docking-Based Comparative Intermolecular Contacts Analysis as New 3-D QSAR Concept for Validating Docking Studies and in Silico Screening: NMT and GP Inhibitors as Case Studies

inferred← citeshttps://doi.org/10.1021/ci200064copenalex-snapshot

Rationalizing the Role of SAR Tolerance for Ligand-Based Virtual Screening

inferred← citeshttps://doi.org/10.1021/ci200309jopenalex-snapshot

REPROVIS-DB: A Benchmark System for Ligand-Based Virtual Screening Derived from Reproducible Prospective Applications

inferred← citeshttps://doi.org/10.1021/ci300146hopenalex-snapshot

GA(M)E-QSAR: A Novel, Fully Automatic Genetic-Algorithm-(Meta)-Ensembles Approach for Binary Classification in Ligand-Based Drug Design

inferred← citeshttps://doi.org/10.1039/d2ra00136eopenalex-snapshot

Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning

inferred← citeshttps://doi.org/10.1039/d6ra06850bopenalex-snapshot

Identification of novel PKR inhibitory chemotypes via integrated molecular modelling and machine learning

inferred← citeshttps://doi.org/10.1080/07391102.2025.2507810openalex-snapshot

Pharmacophore modeling, 2D-QSAR, molecular docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA

inferred← citeshttps://doi.org/10.1080/14756366.2016.1218485openalex-snapshot

Discovery of new heat shock protein 90 inhibitors using virtual co-crystallized pharmacophore generation

inferred← citeshttps://doi.org/10.1124/pr.112.007336openalex-snapshot

Computational Methods in Drug Discovery

inferred← citeshttps://doi.org/10.1186/2191-2858-2-7openalex-snapshot

In silico identification of novel lead compounds with AT1 receptor antagonist activity: successful application of chemical database screening protocol

inferred← citeshttps://doi.org/10.2174/1871520620666191224110600openalex-snapshot

Ligand Based Pharmacophore Modeling Followed by Biological Screening Lead to Discovery of Novel PDK1 Inhibitors as Anticancer Agents

inferred← citeshttps://doi.org/10.21767/2469-6692.10006openalex-snapshot

Discovery of Check Point Kinase 1 (Chk1) Inhibitors as Potential Anticancer Agents Using Ligand-Based Modelling and Virtual Screening

inferred← citeshttps://doi.org/10.4155/fmc-2015-0003openalex-snapshot

Innovative Computer-Aided Methods for the Discovery of New Kinase Ligands

inferred← citeshttps://doi.org/10.4155/fmc-2016-0056openalex-snapshot

Computer-Aided Discovery of New Fgfr-1 Inhibitors Followed by In Vitro Validation

inferred← citeshttps://doi.org/10.4155/fmc.12.148openalex-snapshot

Significance Estimation For Sequence-Based Chemical Similarity Searching (PhAST) And Application To AuroraA Kinase Inhibitors

inferred← citeshttps://doi.org/10.4155/fmc.12.19openalex-snapshot

Virtual Compound Screening In Drug Discovery

inferred← citeshttps://doi.org/10.4155/fmc.12.207openalex-snapshot

Predictive Chemometric Modeling of DPPH Free Radical-Scavenging Activity of Azole Derivatives Using 2D- and 3D-Quantitative Structure–Activity Relationship Tools

inferred← citeshttps://doi.org/10.70675/2b288725z2446z48c5z833ezf53915cd324bopenalex-snapshot

Développement d’outils statistiques d’évaluation de méthodes de criblage virtuel : courbes de prédictivité & Screening Explorer

inferred← citeshttps://doi.org/10.70675/de51bc89z33fez456fz9467z959329cc603bopenalex-snapshot

Optimisation de méthodes de criblage virtuel et synthèse de molécules à visée thérapeutique pour le traitement des maladies auto-immunes.

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.